Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immuno…
Drug Manufacturers - General
US, Kenilworth [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 0.07 | 1.25 | 1.25 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -90.43 | 4.14 | 43.24 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 7.41 | 15.94 | 14.84 | |
| Cash | -20.25 | 2.25 | 2.83 | |
| Capex | 12.94 | -0.34 | -0.39 | |
| Free Cash Flow | 200.00 | 0.88 | -0.29 | |
| Revenue | 8.06 | 6.24 | 5.78 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -2.67 | 0.75 | 0.77 | |
| Operating Margin | 1731.35 | 0.37 | -0.02 | |
| ROA | 291.45 | 0.04 | -0.01 | |
| ROE | 261.64 | 0.12 | -0.03 | |
| ROIC | 2616.91 | 0.07 | < 0.005 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of MRK is permitted for members.
5
Growth
The "Growth Entry" for the Focus of MRK is permitted for members.
6
Leverage & Liquidity